OTC Pharmaceuticals Report 2019 - Analgesics

Statista Consumer Market Outlook - Segment Report

OTC Pharmaceuticals Report 2019 - Analgesics The segment Analgesics accounted for 21% of the total OTC Pharmaceuticals revenue in 2018. The worldwide revenue of US$24 billion in 2018 is expected to increase to US$29 billion by 2023. This report from the series of Consumer Market Outlook segment reports gives an overview of the Analgesics market from an international perspective.


What's included?
  • All relevant sales figures and growth rates, including forecasts until 2023
  • Regional comparison with focus on Europe, United States, China and South America

DescriptionContentTables

The report covers the OTC Pharmaceuticals segment Analgesics, which comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations, that can be purchased without a medical prescription. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included.
Sales by hospitals are not included.

  • Language: English
  • Released: April 2019
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!